Post Conference Perspectives

World Conference on Lung Cancer 2022: Updates in NSCLC

September 16th 2022

Dr Millie Das, MD discusses updates from the 2022 World Conference on Lung Cancer regarding non-small cell lung cancer (NSCLC).

ASH 2021 Post-Conference Perspectives: Updates in Multiple Myeloma

December 23rd 2021

Expert insight on multiple myeloma management updates from the ASH 2021 annual meeting.

ESC Congress 2021: Updates in Chronic Kidney Disease, Heart Failure, and Type 2 Diabetes

September 17th 2021

AMCP Post-Conference Perspectives: Chronic Kidney Disease (CKD)

May 12th 2021

Robert Toto, MD, reviews key takeaways from the 2021 Academy of Managed Care Pharmacy meeting regarding healthcare resource utilization for patients with chronic kidney disease (CKD).

Post Conference Perspective: Immune Checkpoint Inhibitors in Advanced and Metastatic Urothelial Carcinoma

March 10th 2021

Petros Grivas, MD, PhD, reviews emerging data from the 2021 ASCO GU Virtual Symposium on the role of immune checkpoint inhibitors for the treatment of advanced and metastatic urothelial carcinoma.

ASH 2020 Post Conference Perspectives: Updates in Multiple Myeloma

January 22nd 2021

An expert in the field of multiple myeloma discusses key data releases from ASH 2020.

AHA Post Conference Perspectives: Emerging Therapies in Hypertrophic Cardiomyopathy (HCM)

January 11th 2021

An expert in the management of hypertrophic cardiomyopathy discusses the burden of disease, existing treatment options, unmet needs, and explores data from an emerging class of agents, myosin inhibitors.

ID Week 2020: Updates in HIV

January 8th 2021

Infectious disease expert discusses key data releases from ID Week 2020 within the field of HIV care.

The Changing Treatment Landscape of B Cell Malignancies

January 21st 2020

Navigating the Complex Treatment Landscape of Multiple Myeloma in Transplant Eligible Patients

December 19th 2019